228 related articles for article (PubMed ID: 11163583)
1. Cytomegalovirus diagnosis in renal and bone marrow transplant recipients: the impact of molecular assays.
Halwachs-Baumann G; Wilders-Truschnig M; Enzinger G; Eibl M; Linkesch W; Dornbusch HJ; Santner BI; Marth E; Kessler HH
J Clin Virol; 2001 Jan; 20(1-2):49-57. PubMed ID: 11163583
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of the CMV antigenemia test and CMV-DNA PCR results in solid organ transplant recipients].
Özkarata E; Özbek ÖA; Avkan Oğuz V; Sayıner AA
Mikrobiyol Bul; 2016 Jan; 50(1):44-52. PubMed ID: 27058328
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of diagnostic methods for the detection of cytomegalovirus in recipients of allogeneic stem cell transplants.
Preiser W; Bräuninger S; Schwerdtfeger R; Ayliffe U; Garson JA; Brink NS; Franck S; Doerr HW; Rabenau HF
J Clin Virol; 2001 Jan; 20(1-2):59-70. PubMed ID: 11163584
[TBL] [Abstract][Full Text] [Related]
4. Assessment of CMV load in solid organ transplant recipients by pp65 antigenemia and real-time quantitative DNA PCR assay: correlation with pp67 RNA detection.
Mengoli C; Cusinato R; Biasolo MA; Cesaro S; Parolin C; Palù G
J Med Virol; 2004 Sep; 74(1):78-84. PubMed ID: 15258972
[TBL] [Abstract][Full Text] [Related]
5. Differences between the quantitative antigenemia assay and the cobas amplicor monitor quantitative PCR assay for detecting CMV viraemia in bone marrow and solid organ transplant patients.
Flexman J; Kay I; Fonte R; Herrmann R; Gabbay E; Palladino S
J Med Virol; 2001 Jul; 64(3):275-82. PubMed ID: 11424115
[TBL] [Abstract][Full Text] [Related]
6. Human cytomegalovirus immediate-early mRNA detection by nucleic acid sequence-based amplification as a new parameter for preemptive therapy in bone marrow transplant recipients.
Gerna G; Baldanti F; Lilleri D; Parea M; Alessandrino E; Pagani A; Locatelli F; Middeldorp J; Revello MG
J Clin Microbiol; 2000 May; 38(5):1845-53. PubMed ID: 10790111
[TBL] [Abstract][Full Text] [Related]
7. CMV antigenemia and quantitative viral load assessments in hematopoietic stem cell transplant recipients.
Cardeñoso L; Pinsky BA; Lautenschlager I; Aslam S; Cobb B; Vilchez RA; Hirsch HH
J Clin Virol; 2013 Feb; 56(2):108-12. PubMed ID: 23146665
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of nucleic-acid-sequence- based amplification for the detection of cytomegalovirus infection in renal and liver transplant recipients.
Goossens VJ; Blok MJ; Christiaans MH; van Hooff JP; Sillekens P; Höckerstedt K; Lautenschlager I; Middeldorp JM; Bruggeman CA
Intervirology; 1999; 42(5-6):373-81. PubMed ID: 10702720
[TBL] [Abstract][Full Text] [Related]
9. Use of PCR serum in diagnosing and monitoring cytomegalovirus reactivation in bone marrow transplant recipients.
Matsunaga T; Sakamaki S; Ishigaki S; Kohda K; Takeda M; Katoh J; Kuroda H; Hirayama Y; Kusakabe T; Akiyama T; Kuga T; Niitsu Y; Masaoka T; Sagawa T; Matsumoto Y
Int J Hematol; 1999 Feb; 69(2):105-11. PubMed ID: 10071460
[TBL] [Abstract][Full Text] [Related]
10. Comparison of two quantitative CMV PCR tests, Cobas Amplicor CMV Monitor and TaqMan assay, and pp65-antigenemia assay in the determination of viral loads from peripheral blood of organ transplant patients.
Piiparinen H; Höckerstedt K; Grönhagen-Riska C; Lautenschlager I
J Clin Virol; 2004 Jul; 30(3):258-66. PubMed ID: 15135746
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of cytomegalovirus (CMV) antigenemia assay, polymerase chain reaction, serology, and shell vial assay in the early diagnosis and monitoring of CMV infection after renal transplantation.
Tanabe K; Tokumoto T; Ishikawa N; Koyama I; Takahashi K; Fuchinoue S; Kawai T; Koga S; Yagisawa T; Toma H; Ota K; Nakajima H
Transplantation; 1997 Dec; 64(12):1721-5. PubMed ID: 9422409
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of real-time polymerase chain reaction and antigenemia assay to detect cytomegalovirus in pediatric transplants].
Farfán U MJ; Torres T JP; Vergara A A; Donoso W G; Alba G A; Paris D C; Santolaya De P ME
Rev Chilena Infectol; 2011 Apr; 28(2):113-7. PubMed ID: 21720689
[TBL] [Abstract][Full Text] [Related]
13. Different profiles of cytomegalovirus RNA transcripts and anti-cytomegalovirus IgM antibodies in renal transplant recipients.
Goossens VJ; Vink C; Mullers W; Middeldorp JM; Bruggeman CA
J Clin Virol; 2001 Dec; 23(1-2):87-95. PubMed ID: 11595587
[TBL] [Abstract][Full Text] [Related]
14. Monitoring cytomegalovirus infection in adult and pediatric bone marrow transplant recipients by a real-time PCR assay performed with blood plasma.
Leruez-Ville M; Ouachée M; Delarue R; Sauget AS; Blanche S; Buzyn A; Rouzioux C
J Clin Microbiol; 2003 May; 41(5):2040-6. PubMed ID: 12734246
[TBL] [Abstract][Full Text] [Related]
15. Diagnosing cytomegalovirus disease in CMV seropositive renal allograft recipients: a comparison between the detection of CMV DNAemia by polymerase chain reaction and antigenemia by CMV pp65 assay.
Lo CY; Ho KN; Yuen KY; Lui SL; Li FK; Chan TM; Lo WK; Cheng IK
Clin Transplant; 1997 Aug; 11(4):286-93. PubMed ID: 9267717
[TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus antigenemia assay or PCR can be used to monitor ganciclovir treatment in bone marrow transplant recipients.
Vlieger AM; Boland GJ; Jiwa NM; de Weger RA; Willemze R; de Gast GC; Falkenburg JH
Bone Marrow Transplant; 1992 Apr; 9(4):247-53. PubMed ID: 1318141
[TBL] [Abstract][Full Text] [Related]
17. Cytomegalovirus (CMV) DNA amplification from plasma compared with CMV pp65 antigen (ppUL83) detection in leukocytes for early diagnosis of symptomatic CMV infection in kidney transplant patients.
Wirgart BZ; Claesson K; Eriksson BM; Brundin M; Tufveson G; Tötterman T; Grillner L
Clin Diagn Virol; 1996 Nov; 7(2):99-110. PubMed ID: 9137866
[TBL] [Abstract][Full Text] [Related]
18. Monitoring of cytomegalovirus reactivation in bone marrow transplant recipients by real-time PCR.
Ghaffari SH; Obeidi N; Dehghan M; Alimoghaddam K; Gharehbaghian A; Ghavamzadeh A
Pathol Oncol Res; 2008 Dec; 14(4):399-409. PubMed ID: 18392952
[TBL] [Abstract][Full Text] [Related]
19. Analysis of cytomegalovirus (CMV) viremia using the pp65 antigenemia assay, the amplicor CMV test, and a semi-quantitative polymerase chain reaction test after allogeneic marrow transplantation.
Ksouri H; Eljed H; Greco A; Lakhal A; Torjman L; Abdelkefi A; Ben Othmen T; Ladeb S; Slim A; Zouari B; Abdeladhim A; Ben Hassen A
Transpl Infect Dis; 2007 Mar; 9(1):16-21. PubMed ID: 17313466
[TBL] [Abstract][Full Text] [Related]
20. A prospective study comparing cytomegalovirus antigenemia, DNAemia and RNAemia tests in guiding pre-emptive therapy in thoracic organ transplant recipients.
Lehto JT; Lemström K; Halme M; Lappalainen M; Lommi J; Sipponen J; Harjula A; Tukiainen P; Koskinen PK
Transpl Int; 2005 Dec; 18(12):1318-27. PubMed ID: 16297050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
